Eagle Pharmaceuticals shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Eagle Pharmaceuticals by T. Rowe Price Associates
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $50k | 13k | 3.76 |
2024-06-30 | $75k | 13k | 5.64 |
2024-03-31 | $83k | 16k | 5.27 |
2022-12-31 | $465k | 16k | 29.26 |
2022-03-31 | $648k | 13k | 49.51 |
2021-12-31 | $676k | 13k | 50.95 |
2021-09-30 | $752k | 14k | 55.81 |
2021-06-30 | $577k | 14k | 42.79 |
2021-03-31 | $628k | 15k | 41.76 |
2020-12-31 | $924k | 20k | 46.57 |
2020-09-30 | $1.1M | 26k | 42.48 |
2020-06-30 | $901k | 19k | 47.96 |
2020-03-31 | $931k | 20k | 46.01 |
2019-12-31 | $948k | 16k | 60.11 |
2019-09-30 | $864k | 15k | 56.57 |
2019-06-30 | $836k | 15k | 55.65 |
2019-03-31 | $757k | 15k | 50.46 |
2018-12-31 | $602k | 15k | 40.27 |
2018-09-30 | $910k | 13k | 69.31 |
2018-06-30 | $682k | 9.0k | 75.70 |
2018-03-31 | $473k | 9.0k | 52.72 |
2017-12-31 | $476k | 8.9k | 53.46 |
2017-06-30 | $4.1M | 51k | 78.89 |
2017-03-31 | $512k | 6.2k | 83.00 |
2016-12-31 | $886k | 11k | 79.33 |
2016-09-30 | $658k | 9.4k | 69.96 |